In 2002, Josh, along with Dr. Eli Gang and some top medical and business partners founded Magnetecs Corporation

in order to develop his vision for a better way to allow a physician to control the movement of a catheter within a patient. The resulting Catheter Guidance Control and Imaging (CGCI) system was the first magnetically controlled, robotic-assisted catheter guidance system to use proprietary imaging and magnetic field lensing technologies to accurately map the target area of a patient in a three-dimensional image in real-time and then use that information to robotically guide a catheter directly to site in order to perform whatever procedure is required. Originally designed for the ablation of cardiac arrhythmias associated with AFib, CGCI had wide applications across a variety of disease treatments.

With the success of Magnetecs, Josh turned his attention to other key innovations including an innovative Implantable Smart Drug Delivery system that dramatically changes the ability to effectively deliver therapeutics for patients suffering a variety of hard-to-treat disease issues such as brain cancer and malignant glioma. In addition, Josh is the inventor of several new technologies that use advanced biosensors to rapidly detect biomarkers of a target of interest in a sample at clinically relevant values at concentration levels much lower than current methodologies allow. By being able to detect a biomarker at its early stage appearance in a patient, disease diagnosis and treatment can occur much quicker. These technologies hold a promise to completely revision diagnostic medicine in order to have a major impact on pathogen detection for issues such as Ebola, Marburg, HIV, and many others. Early detection with this technology may be key in stopping an infection from becoming a pandemic such as we experienced with the recent COVID-19 virus. In 2013 and 2014, Josh’s biosensor technology was awarded “Innovation of the Year” and “Best Practices Award” by the global medical technology review firm of Frost and Sullivan.